Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

Revenue $2.91 billion $2.78 billion $2.52 billion 15.7% Net Income (non-GAAP) $1.04 billion N/A $1.10 billion (5.5%) R&D and SG&A expenses (non-GAAP) $1.21 billion N/A $984 million 22.9% Vertex ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Get Up and Running This manual simplifies the process of setting up and using your new Nintendo 64 Manuals with clear instructions and illustrations. Before using your Nintendo 64 Manuals, please ...

FT Strategic Income Select CE 69 CA 18.97 FT Strategic Income Select CE 69 RE 18.97 Indices Commodities Currencies Stocks ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

President Donald Trump’s destructive trade war could devastate New Mexico’s economy. Our state’s trade economy benefits more than just our border communities — it supports jobs and ...

HUNTINGTON — The Cabell County Board of Education will discuss disposing of its former Highlawn Elementary School property at 2549 1st Ave. during its regular meeting Tuesday. The meeting will ...

Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. We recently compiled a ...